A 12‐week, randomized, double‐blind, placebo‐controlled, four‐arm dose‐finding phase 2 study evaluating bexagliflozin as monotherapy for adults with type 2 diabetes

2019 ◽  
Vol 22 (4) ◽  
pp. 566-573 ◽  
Author(s):  
Yuan‐Di Halvorsen ◽  
Geoffrey Walford ◽  
Tara Thurber ◽  
Heidy Russell ◽  
Monica Massaro ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document